Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
Anteris Technologies Ltd
AVRAnteris Technologies Ltd, a structural heart company, engages in the designing, developing, and commercializing medical devices. The company's lead product candidate is DurAVR, a transcatheter heart valve (THV) for the treatment of aortic stenosis. It also offers ComASUR, a delivery system that provides controlled deployment and placement of the DurAVR THV with balloon-expandable delivery, which allow precise alignment of the heart's native commissures to achieve ideal valve positioning; and ADAPT, a patented anti-calcification tissue technology. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia. Address: Toowong Tower, Toowong, QLD, Australia, 4066
Analytics
Objectif de Cours de WallStreet
40.31 AUDRatio C/B
–Rendement du dividende
–Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés AVR
Analyse des dividendes AVR
Croissance des dividendes sur 5 ans
–Croissance continue
–Ratio de distribution Moyenne sur 5 ans
–Historique des dividendes AVR
Valorisation des titres AVR
financières AVR
Résultats | 2019 | Dynamique |